A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma

Table 5

Correlation between serum level of lncRNAs UBE2CP3 and UCA1 and clinicopathological characteristics in 129 HCC patients.

Features	UBE2CP3			UCA1
	Low ()	High ()		Low ()	High ()
Gender			0.636			0.972
Male	55	56		55	56
Female	10	8		9	9
Age			0.092			0.058
≤55	22	31		21	32
>55	43	33		43	33
HBsAg			0.796			0.558
Positive	51	49		51	49
Negative	14	15		13	16
AFP level			0.372			0.702
≤20 ng/mL	30	25		26	29
>20 ng/mL	34	39		37	36
Tumor size			0.803			0.803
≤3 cm	20	21		21	20
>3 cm	45	43		43	45
Tumor number			0.329			0.668
Single	56	51		54	53
Multiple	9	13		10	12
GGT (U/L)	67 (13-888)	83.5 (14-2000)	0.182	72.5 (13-2000)	81 (14-1034)	0.156
ALT (U/L)	36 (7-338)	38 (12-1198)	0.617	42 (7-402)	37 (12-1198)	0.871
AST (U/L)	37 (18-577)	47.5 (17-1474)	0.170	38.5 (17-577)	42 (17-1474)	0.821
TP (g/L)	69.5 (56.8-80.6)	67.8 (43.4-84.8)	0.171	69.1 (55.3-80.6)	68.4 (43.4-84.8)	0.858
ALB (g/L)	40.3 (23.9-48.9)	39.2 (21.4-48.6)	0.414	40.4 (23.8-47.2)	39.4 (21.4-48.9)	0.391

AFP: alpha fetoprotein; GGT: gamma-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartic transaminase; TP: total protein; ALB: albumin.